Lir Life Sciences Corp.: LIR Life Sciences Reports Positive Interim Preclinical Results from Comparative Animal Study of Novel CPP-Enabled Transdermal Delivery of GLP/GIP-Based ...

VANCOUVER, BC / ACCESS Newswire / January 29, 2026 / LIR Life Sciences Corp. (CSE:SKNY)(OTC PINK:BBCMF)(Frankfurt:N790, WKN:A41QA9) ("LIR" or the "Company")is pleased to announce positive interim resu ...

Groundbreaking comparative study reveals best treatment for diabetes

Groundbreaking comparative study reveals best treatment for diabetes - Findings point to a paradigm shift in diabetes care, ...
PharmiWeb

LIR Life Sciences Launches Comparative Animal Study to Advance Transdermal Delivery of Second Generation GLP/GIP-based Obesity Therapies

VANCOUVER, BC / ACCESS Newswire / January 15, 2026 / LIR Life Sciences Corp. (CSE:SKNY)(OTC PINK:BBCMF)(Frankfurt:N790, WKN:A41QA9) ("LIR" or the "Company")is pleased to announce the launch of a ...
EurekAlert!

Biopsychosocial impact of multiple sclerosis in Omani patients: a multicenter comparative study

Although the Sultanate of Oman has a relatively low prevalence of MS (15 cases per 100,000 people) compared to other Gulf countries, understanding the psychological, cognitive, and social ...